๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden flag Sweden ยท Delayed Price ยท Currency is SEK
5.68
-0.16 (-2.74%)
Nov 20, 2026, 5:29 PM CET

AlzeCure Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
163.52-----
Revenue Growth
------
Gross Profit
163.52-----
Operating Income
92.25-47.97-35.99-38.34-56.57-78.14
Net Income
93.02-47.65-35.35-37.17-56.24-77.78
Earnings Per Share
0.72-0.47-0.46-0.60-1.18-2.06
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
231.9350.3431.529.125.5841.74
Total Debt
1.723.864.93---
Net Cash (Debt)
230.2246.4826.5729.125.5841.74
Net Cash Growth
308.51%74.96%-8.71%13.77%-38.73%-62.88%
Net Cash Per Share
1.780.460.340.470.541.11

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
99.07-34.59-34.233.06-99.91-70.64
Capital Expenditures
---0.12---0.05
Free Cash Flow
99.07-34.59-34.353.06-99.91-70.69
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%-----
Operating Margin
56.42%-----
Profit Margin
56.88%-----
FCF Margin
60.59%-----

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.337.332.35--
P/FCF Ratio
7.91--63.16--